Stay updated on Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Sign up to get notified when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.

Latest updates to the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page
- Check4 days agoChange DetectedRevision label updated to v3.5.4, indicating a new site release. This reflects a platform/UI update rather than changes to study data or page content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe history now marks the study as Terminated with < 75% participation, replacing the previous Active, not recruiting status, with a last update date of 2026-04-27; the history also introduces new sections and a new revision (v3.5.3) in the record.SummaryDifference0.9%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision v3.5.0 was added to the history and revision v3.4.3 was removed.SummaryDifference0.2%

- Check68 days agoChange DetectedThe history page shows a new 2026-03-05 entry adding a Study Status item and a Revision: v3.4.3. The 2025-09-05 entry (Revision: v3.4.2) was removed.SummaryDifference0.5%

- Check97 days agoChange DetectedThe page history now includes a new entry: Revision: v3.4.2, and older items—the Notice about government funding lapse and Revision: v3.4.1—were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.